Analytics

Aug 09, 2018
By BioPharm International Editors
The Alliance for Regenerative Medicine’s (ARM) report highlights major trends and metrics from the 2018 second quarter in the regenerative medicines sector.
Aug 01, 2018
BioPharm International
Materials in contact with a drug must be fully characterized to ensure they do not negatively affect the safety and efficacy of the product.
Aug 01, 2018
BioPharm International
More complex biologic samples must be evaluated to ever higher levels of specificity and sensitivity.
Jul 19, 2018
By BioPharm International Editors
FDA and ICH seek comment on new exposure levels for cadmium in drug products.
Jul 01, 2018
BioPharm International
Process analytical technology tools have enabled manufacturers to monitor and control their production processes.
Jul 01, 2018
BioPharm International
Biopharma companies can balance competing demands from patients, investors, and regulators by keeping a focus on science.
Jun 01, 2018
BioPharm International
Transcriptomics plays a role in influencing the production of recombinant therapeutics in microbial and mammalian hosts.
Jun 01, 2018
BioPharm International
This article discusses affinity capture for tier determination and surveys a broad collection of commonly and less commonly used assays to analyze cell culture media.
May 01, 2018
By BioPharm International Editors
Geofrey Wyatt has been named CEO and Clifford Wyatt named president of Wyatt Technology.
May 01, 2018
BioPharm International
Process understanding and careful assessment of risks are essential in developing viral clearance programs.
native1_300x100
lorem ipsum